Bladder cancer chemotherapy: is response of squamous tumours different to that of transitional cell tumours?
Related Experiment Videos
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prognostic factors for renal cell carcinoma.
Cancer treatment reviews·2008
The role of surgery in the multimodality treatment of bladder cancer.
Cancer surveys·2004
Testicular microlithiasis: is it a benign condition with malignant potential?
European urology·2001
Prospective circulating tumour DNA surveillance in patients with early high-risk hormone receptor positive, HER2-negative breast cancer in the TRAK-ER study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Final Analysis of the Neotorch Study: Perioperative Toripalimab in Combination with Chemotherapy for Patients with Stage Ⅱ/Ⅲ Resectable Non-Small Cell Lung Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sacituzumab tirumotecan versus chemotherapy in previously treated locally recurrent or metastatic triple-negative breast cancer: final overall survival analysis of the Phase III OptiTROP-Breast01.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Efficacy and safety of risvutatug rezetecan versus gemcitabine plus docetaxel in relapsed/refractory advanced osteosarcoma: Primary results from the ARTEMIS-011 phase 3 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase III DeLLphi-304 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Clinical Complete Response with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer: First Results from the Global AZUR-1 Trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026